Wells Fargo Reiterates Equal Weight Rating on Horizon Therapeutics (HZNP) as Potential FTC Lawsuit Increases Risk to Amgen (AMGN) Deal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Wells Fargo Reiterates Equal Weight Rating on Horizon Therapeutics (HZNP) as Potential FTC Lawsuit Increases Risk to Amgen (AMGN) Deal
HORIZON PHARMA (NASDAQ: HZNP) Delayed: 116.30 --0 (-0%)
Previous Close $116.30    52 Week High $23.44 
Open $19.84    52 Week Low $13.06 
Day High $116.30    P/E N/A 
Day Low $116.30    EPS $-0.96 
Volume 283,408